• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)

    4/11/25 6:38:36 PM ET
    $BCPC
    Major Chemicals
    Industrials
    Get the next $BCPC alert in real time by email
    SEC FORM 4/A SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Reid Martin Luther

    (Last) (First) (Middle)
    C/O BALCHEM CORPORATION
    5 PARAGON DRIVE

    (Street)
    MONTVALE NJ 07645

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BALCHEM CORP [ BCPC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    SVP Chief Supply Chain Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    02/12/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    02/14/2025
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 02/12/2025 A 1,000(1) A $0 6,761 D
    Common Stock 02/13/2025 A 2,889(2) A $0 9,650 D
    Common Stock 02/13/2025 F 1,059(3) D $163.14 8,591 D
    Common Stock 561 I 401(k) Plan
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option $159.18 02/12/2025 A 3,300 (4) 02/12/2035 Common Stock 3,300 $0 3,300 D
    Explanation of Responses:
    1. Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
    2. Represents the vesting of performance stock units (includes 47 dividend equivalent shares) for the 2022-2024 performance period.
    3. 1,059 of the 2,889 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
    4. Options vest 20% Year 1; 40% Year 2; and 40% Year 3.
    Remarks:
    This Form 4/A amends and restates the original Form 4 filed on February 14, 2025, which inadvertently noted the vesting period for restricted stock as 3 years from the grant date, instead of a ratable vesting over a 3-year period.
    /s/ Travis Larsen, Attorney in Fact for Martin Luther Reid 04/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BCPC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BCPC

    DatePrice TargetRatingAnalyst
    3/8/2022$170.00 → $155.00Buy
    HC Wainwright & Co.
    2/22/2022$175.00Neutral → Buy
    Sidoti
    1/10/2022$160.00 → $170.00Buy
    HC Wainwright & Co.
    11/29/2021$175.00Buy → Neutral
    Sidoti
    8/2/2021$140.00 → $145.00Overweight → Equal-Weight
    Stephens & Co.
    8/2/2021$145.00 → $160.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BCPC
    SEC Filings

    See more
    • SEC Form 11-K filed by Balchem Corporation

      11-K - BALCHEM CORP (0000009326) (Filer)

      6/24/25 4:38:30 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - BALCHEM CORP (0000009326) (Filer)

      6/20/25 4:16:23 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Balchem Corporation

      SCHEDULE 13G/A - BALCHEM CORP (0000009326) (Subject)

      5/14/25 4:34:20 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025

      MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Annual New Ideas Summer Conference on July 10, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest qual

      6/26/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025

      MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the fi

      5/28/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025

      MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the dbAccess Global Consumer Conference on June 4, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President and Martin Bengtsson, Chief Financial Officer will participate at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The

      5/21/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 2,128 shares and covered exercise/tax liability with 964 shares, increasing direct ownership by 14% to 9,446 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 7:11:10 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP & Chief HR Officer Tignor Michael Brent was granted 3,497 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 35% to 9,123 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:43:35 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:38:36 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $155.00 from $170.00 previously

      3/8/22 6:19:56 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem upgraded by Sidoti with a new price target

      Sidoti upgraded Balchem from Neutral to Buy and set a new price target of $175.00

      2/22/22 8:56:13 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $170.00 from $160.00 previously

      1/10/22 6:15:56 AM ET
      $BCPC
      Major Chemicals
      Industrials